Neurodevelopmental outcome of extremely premature infants exposed to incomplete, no or complete antenatal steroids

Abstract Objective: To compare the neurodevelopmental outcomes at 18–22 months’ corrected age of extremely premature infants exposed to a complete course, an incomplete course or no dose of antenatal steroids (ANS). Methods: Retrospective chart review of extremely premature (<28 weeks gestational age) neonates over a 3-year period. Neurodevelopmental assessment at 18–22 months’ corrected age included a standardized neurologic examination and the Bayley Scales of Infant and Toddler development II or III. Intact survival was defined as survival without cerebral palsy (CP), blindness or deafness and mental developmental index (MDI)/cognitive score ≥85. Neurodevelopmental impairment (NDI) was defined as any of the following: moderate or severe CP, MDI/cognitive score <70, deafness or blindness. Patients were categorized into three groups: (A) no ANS; (B) incomplete course and (C) complete course of ANS. Results: Outcome data were available for 134 (88%) patients of our cohort (n = 153). Severe intraventricular hemorrhage (IVH) was significantly lower and intact survival was higher in the complete ANS group (p < 0.01). On logistic regression, with gestational age, gender, maternal insurance and ANS exposure as covariates, an incomplete (versus complete) course of ANS (p = 0.006) and gestational age were significantly associated with lower intact survival at 18–22 months. Conclusions: A complete course of ANS was associated with an increased likelihood of intact survival at a corrected age of 18–22 months among extremely premature infants, compared with an incomplete course. Follow-up studies should account for the differential benefit of complete versus incomplete course of ANS administration.

[1]  B. Milcarek,et al.  Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. , 2012, American journal of obstetrics and gynecology.

[2]  B. Poindexter,et al.  Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation. , 2011, JAMA.

[3]  B. Vohr,et al.  Early-Childhood Neurodevelopmental Outcomes Are Not Improving for Infants Born at <25 Weeks' Gestational Age , 2011, Pediatrics.

[4]  B. Vohr,et al.  Early-Childhood Neurodevelopmental Outcomes Are Not Improving for Infants Born at , 2010 .

[5]  Z. Ungvari,et al.  Effect of Prenatal Glucocorticoids on Cerebral Vasculature of the Developing Brain , 2010, Stroke.

[6]  S. Chawla,et al.  Outcomes of extremely low birth weight infants with varying doses and intervals of antenatal steroid exposure , 2010, Journal of perinatal medicine.

[7]  D. Walker,et al.  The Effect of Betamethasone Treatment on Neuroactive Steroid Synthesis in a Foetal Guinea Pig Model of Growth Restriction , 2010, Journal of neuroendocrinology.

[8]  Reese H Clark,et al.  New Intrauterine Growth Curves Based on United States Data , 2010, Pediatrics.

[9]  B. Haglund,et al.  Short and long‐term effects of antenatal corticosteroids assessed in a cohort of 7,827 children born preterm , 2009, Acta obstetricia et gynecologica Scandinavica.

[10]  S. Malaeb,et al.  Effects of maternal antenatal glucocorticoid treatment on apoptosis in the ovine fetal cerebral cortex , 2009, Journal of neuroscience research.

[11]  M. Kaminski,et al.  Impact of the use of antenatal corticosteroids on mortality, cerebral lesions and 5‐year neurodevelopmental outcomes of very preterm infants: the EPIPAGE cohort study , 2007, BJOG : an international journal of obstetrics and gynaecology.

[12]  Julie Brown,et al.  Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth , 2007, The Cochrane database of systematic reviews.

[13]  A. Spitzer,et al.  Antenatal Corticosteroids: Are Incomplete Courses Beneficial? , 2003, Obstetrics and gynecology.

[14]  P. Leroux,et al.  Glucocorticoid treatment in an ischaemic‐like excitotoxic model of periventricular leucomalacia in mice , 2002, BJOG : an international journal of obstetrics and gynaecology.

[15]  M. Durkin,et al.  Long-term cognitive benefits of antenatal corticosteroids for prematurely born children with cranial ultrasound abnormalities. , 2002, American journal of obstetrics and gynecology.

[16]  S. Grobler,et al.  The use of dexamethasone in women with preterm premature rupture of membranes--a multicentre, double-blind, placebo-controlled, randomised trial. Dexiprom Study Group. , 1999, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[17]  N. Bayley.  Bayley Scales of Infant Development , 1999 .

[18]  W. H. Hall,et al.  Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes: NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes , 1995 .

[19]  M. Hallman,et al.  Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. , 1994, Pediatrics.

[20]  I. Chalmers,et al.  The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials , 1990, British journal of obstetrics and gynaecology.

[21]  L. Papile,et al.  Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. , 1978, The Journal of pediatrics.

[22]  M. J. Bell,et al.  Neonatal Necrotizing Enterocolitis: Therapeutic Decisions Based upon Clinical Staging , 1978, Annals of surgery.

[23]  G. Liggins,et al.  A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. , 1972, Pediatrics.

[24]  Craig A. Albers,et al.  Third Edition. San Antonio, TX: Harcourt Assessment - Test Review: Bayley, N. (2006). Bayley Scales of Infant and Toddler Development , 2014 .

[25]  B. Milcarek,et al.  16: Betamethasone dosing interval–12 or 24 hours apart? , 2011 .

[26]  M. Monga,et al.  Continuation of pregnancy after antenatal corticosteroid administration: opportunity for rescue? , 2010, The Journal of reproductive medicine.

[27]  M. Funk,et al.  THE USE OF DEXAMETHASONE IN WOMEN WITH PRETERM PREMATURE RUPTURE OF MEMBRANES A MULTICENTRE, DOUBLE-BLIND, PLACEBO CONTROLLED, RANDOMISED TRIAL , 2008 .